C-LEARN: A New Approach To Teach Robots With Robots

May 16, 2017 Vijay Soni 0

C-LEARN: A New Approach To Teach Robots With Robots Source: Adam Conner-Simons | CSAIL MIT May 10, 2017 Most robots are programmed using one of two methods: learning from demonstration, in which they watch a task being done and then replicate it, or via motion-planning techniques such as optimization or sampling, [..]

Noval Way To Clear Pollutants From Water

May 14, 2017 Vijay Soni 0

Noval Way To Clear Pollutants From Water By: David L. Chandler | MIT News Office May 14, 2017 When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective [..]

New Chemical “Dye” To Improve Liver Cancer Imaging

May 14, 2017 Vijay Soni 0

New Chemical “Dye” To Improve Liver Cancer Imaging By: NUS News 14 May 2017 Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based contrast agent – a chemical “dye” used to enhance the visibility of internal body structures in magnetic resonance imaging (MRI) – that improves visualisation of liver [..]

A New Leap In Quantum Computing By Stanford Team

May 11, 2017 Vijay Soni 0

A New Leap In Quantum Computing By Stanford Team By: Tom Abate (Stanford News) May 11, 2017 For 60 years computers have become smaller, faster and cheaper. But engineers are approaching the limits of how small they can make silicon transistors and how quickly they can push electricity through devices to [..]

Exotic Electronic States of Graphene

May 9, 2017 Vijay Soni 0

Exotic Electronic States of Graphene Source: Jennifer Chu | MIT News Office May 9, 2017 In normal conductive materials such as silver and copper, electric current flows with varying degrees of resistance, in the form of individual electrons that ping-pong off defects, dissipating energy as they go. Superconductors, by contrast, [..]

FDA Approve RADICAVA™ of MT Pharma America To Treat ALS

May 8, 2017 Vijay Soni 0

FDA Approve RADICAVA™ of MT Pharma America To Treat ALS First FDA-approved ALS treatment option in more than 20 years1 RADICAVA has been demonstrated to slow decline of physical function by 33 percent2 Comprehensive clinical development program in ALS conducted over a 13-year period2 Source: MT America News May 9, [..]

FDA Granted Approval To Novartis Rydapt® For Acute Myeloid Leukemia

May 2, 2017 Vijay Soni 0

FDA Granted Approval To Novartis Rydapt® For Acute Myeloid Leukemia Approval in newly diagnosed FLT3-mutated AML represents the first new treatment in more than 25 years[1],[2]  Rydapt treatment regimen in FLT3-mutated AML demonstrated a significant improvement in overall survival with a 23% reduction in the risk of death[3]  Rydapt is [..]